Report from the American Society of Transplantation on frailty in solid organ transplantation
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
A consensus conference on frailty in kidney, liver, heart, and lung transplantation sponsored by the American Society of Transplantation (AST) and endorsed by the American Society of Nephrology (ASN), the American Society of Transplant Surgeons (ASTS), and the Canadian Society of Transplantation (CST) took place on February 11, 2018 in Phoenix, Arizona. Input from the transplant community through scheduled conference calls enabled wide discussion of current concepts in frailty, exploration of best practices for frailty risk assessment of transplant candidates and for management after transplant, and development of ideas for future research. A current understanding of frailty was compiled by each of the solid organ groups and is presented in this paper. Frailty is a common entity in patients with end-stage organ disease who are awaiting organ transplantation, and affects mortality on the waitlist and in the posttransplant period. The optimal methods by which frailty should be measured in each organ group are yet to be determined, but studies are underway. Interventions to reverse frailty vary among organ groups and appear promising. This conference achieved its intent to highlight the importance of frailty in organ transplantation and to plant the seeds for further discussion and research in this field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601 · cited 1×
“Sarcopenia and frailty share similar underlying mechanisms, such as physical inactivity, chronic inflammation, and endocrine dysregulation (7,8,12).”
BackgroundClegg, A., Young, J., Iliffe, S., Rikkert, M. O., & Rockwood, K. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62167-9 · Cited by 9,503
Frailty in relation to the accumulation of deficits
Rockwood, K., & Mitnitski, A. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.7.722 · Cited by 3,076
A questionnaire for the assessment of leisure time physical activities
Taylor, H. L., Jacobs, D. R., Schucker, B., Knudsen, J., Leon, A. S., & Debacker, G. (1978) · Journal of Chronic Diseases · doi:10.1016/0021-9681(78)90058-9 · Cited by 1,848
Sarcopenia from mechanism to diagnosis and treatment in liver disease
Dasarathy, S., & Merli, M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.040 · Cited by 608 · cited 1×
“Unique to cirrhosis are the contributions of hepatic synthetic dysfunction on accelerating muscle protein breakdown, as well as the deleterious effects of impaired detoxification of ammonia on muscle health (11).”
BackgroundDevelopment of a novel frailty index to predict mortality in patients with end‐stage liver disease
Lai, J. C., Covinsky, K. E., Dodge, J. L., Boscardin, W. J., Segev, D. L., Roberts, J. P., & Feng, S. (2017) · Hepatology · doi:10.1002/hep.29219 · Cited by 556 · cited 6×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript Research is underway to develop organ-specific frailty scores such as the Liver Frailty Index (54) for patients with cirrhosis awaiting liver transplantation or the Essential Frailty Toolset for older adults with advanced aortic valve dise…”
BackgroundInfluentialSelf-citationSarcopenia and Physical Frailty: Two Sides of the Same Coin
Cesari, M., Landi, F., Vellas, B., Bernabei, R., & Marzetti, E. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00192 · Cited by 468
van Vugt, J. L. A., Levolger, S., de Bruin, R. W. F., van Rosmalen, J., Metselaar, H. J., & IJzermans, J. N. M. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13732 · Cited by 361
Sarcopenia as the biological substrate of physical frailty
Landi, F., Calvani, R., Cesari, M., Tosato, M., Martone, A. M., Bernabei, R., Onder, G., & Marzetti, E. (2015) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2015.04.005 · Cited by 288 · cited 1×
“targeting the skeletal muscle may help to prevent or manage frailty (10).”
BackgroundSinclair, M., Grossmann, M., Hoermann, R., Angus, P. W., & Gow, P. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.007 · Cited by 269 · cited 1×
“A single randomized clinical trial of intramuscular testosterone in hypogonadal men with cirrhosis demonstrated improvements in muscle mass, with a trend to increases in strength (65).”
BackgroundFrailty phenotypes, disability, and outcomes in adult candidates for lung transplantation
Singer, J. P., Diamond, J. M., Gries, C. J., McDonnough, J., Blanc, P. D., Shah, R., Dean, M. Y., Hersh, B., Wolters, P. J., Tokman, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1150oc · Cited by 224
Self-citationLanger, D., Burtin, C., Schepers, L., Ivanova, A., Verleden, G., Decramer, M., Troosters, T., & Gosselink, R. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04000.x · Cited by 170 · cited 1×
“Several smaller studies and one randomized, controlled trial evaluating patients receiving pre- and post- lung transplant rehabilitation, suggest that there may be some improvement in muscle function (six-minute walk test and physical activity time) and strength (measured by quadriceps torque) by six months post-trans…”
BackgroundFrailty phenotypes and mortality after lung transplantation: a prospective cohort study
Singer, J. P., Diamond, J. M., Anderson, M. R., Katz, P. P., Covinsky, K., Oyster, M., Blue, T., Soong, A., Kalman, L., Shrestha, P., et al. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14873 · Cited by 133 · cited 1×
“Singer et al demonstrated that phenotypic frailty, utilizing either the FFP or the SPPB, was prevalent in lung transplant candidates and was associated with disability and delisting or death prior to transplant as well as 1- and 4-year mortality after transplant (23,24).”
MethodSelf-citation
Cited by
ESPEN guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease
Fiaccadori, E., Sabatino, A., Barazzoni, R., Carrero, J. J., Cupisti, A., De Waele, E., Jonckheer, J., Singer, P., & Cuerda, C. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.01.028 · Cited by 277
Frailty trajectories in adult lung transplantation: a cohort study
Venado, A., McCulloch, C., Greenland, J. R., Katz, P., Soong, A., Shrestha, P., Hays, S., Golden, J., Shah, R., Leard, L. E., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.03.006 · Cited by 67
Self-citationSabatino, A., Fiaccadori, E., Barazzoni, R., Carrero, J. J., Cupisti, A., De Waele, E., Jonckheer, J., Cuerda, C., & Bischoff, S. C. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.08.002 · Cited by 40
“It has been suggested to intravenously administer about 3 mg/d of copper to prevent de fi ciencies (based on repeated determinations in patients on hemodialysis) [179].”
Metadata
- Authors
- Kobashigawa, J., Dadhania, D., Bhorade, S., Adey, D., Berger, J., Bhat, G., Budev, M., Duarte-Rojo, A., Dunn, M., Hall, S., Harhay, M. N., Johansen, K. L., Joseph, S., Kennedy, C. C., Kransdorf, E., Lentine, K. L., Lynch, R. J., McAdams-DeMarco, M., Nagai, S., Olymbios, M., Patel, J., Pinney, S., Schaenman, J., Segev, D. L., Shah, P., Singer, L. G., Singer, J. P., Sonnenday, C., Tandon, P., Tapper, E., Tullius, S. G., Wilson, M., Zamora, M., & Lai, J. C.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 19
- Issue
- 4
- Pages
- 984-994
- ISSN
- 1600-6135 (ISSN-L)
- OpenAlex
- W2902279724
- Cited by
- 236
- References
- 14
- FWCI
- 12.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.